Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma? ; volume:7 ; number:1 ; day:8 ; month:2 ; year:2019 ; pages:1-10 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (8.2.2019), 1-10, 12.2019
- Creator
-
Wang, Meihua
Chen, Cong
Jemielita, Thomas
Anderson, James
Li, Xiaoyun (Nicole)
Hu, Chen
Kang, S. Peter
Ibrahim, Nageatte
Ebbinghaus, Scot
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0513-4
- URN
-
urn:nbn:de:101:1-2019031017204782509199
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Meihua
- Chen, Cong
- Jemielita, Thomas
- Anderson, James
- Li, Xiaoyun (Nicole)
- Hu, Chen
- Kang, S. Peter
- Ibrahim, Nageatte
- Ebbinghaus, Scot
- SpringerLink (Online service)
Other Objects (12)
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Mixed Response to Immunotherapy in Patients with Metastatic Melanoma
Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Mixed Response to Immunotherapy in Patients with Metastatic Melanoma
Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Mixed Response to Immunotherapy in Patients with Metastatic Melanoma
Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Molecular patterns of resistance to immune checkpoint blockade in melanoma